Regulation of the Spontaneous Augmentation of NaV1.9 in Mouse Dorsal Root Ganglion Neurons: Effect of PKA and PKC Pathways by Kakimura, Jun-ichi et al.
 
Mar. Drugs 2010, 8, 728-740; doi:10.3390/md8030728 
 
Marine Drugs  
ISSN 1660-3397 
www.mdpi.com/journal/marinedrugs 
Article 
Regulation of the Spontaneous Augmentation of NaV1.9 in 
Mouse Dorsal Root Ganglion Neurons: Effect of PKA and PKC 
Pathways 
Jun-ichi Kakimura 
1,2,*, Taixing Zheng 
2, Noriko Uryu 
2 and Nobukuni Ogata 
2  
1  Technical Center, Hiroshima University, Hiroshima, 734-8551, Japan 
2  Department of Neurophysiology, Graduate School of Biomedical Sciences, Hiroshima University, 
Hiroshima, 734-8551, Japan; E-Mails: tei0322@hiroshima-u.ac.jp (T.Z.); uryu@asahi.ac.jp (N.U.); 
ogatan@hiroshima-u.ac.jp (N.O.) 
*  Author to whom correspondence should be addressed; E-Mail: kakimura@hiroshima-u.ac.jp; 
Tel.: +81-82-257-5127; Fax: +81-82-257-5127. 
Received: 15 January 2010; in revised form: 8 February 2010 / Accepted: 18 March 2010 /  
Published: 19 March 2010 
 
Abstract: Sensory neurons in the dorsal root ganglion express two kinds of tetrodotoxin 
resistant (TTX-R) isoforms of voltage-gated sodium channels, NaV1.8 and NaV1.9. These 
isoforms play key roles in the pathophysiology of chronic pain. Of special interest is 
NaV1.9: our previous studies revealed a unique property of the NaV1.9 current, i.e., the 
NaV1.9 current shows a gradual and notable up-regulation of the peak amplitude during 
recording (“spontaneous augmentation of NaV1.9”). However, the mechanism underlying 
the spontaneous augmentation of NaV1.9 is still unclear. In this study, we examined the 
effects of protein kinases A and C (PKA and PKC), on the spontaneous augmentation of 
NaV1.9. The spontaneous augmentation of the NaV1.9 current was significantly suppressed 
by activation of PKA, whereas activation of PKA did not affect the voltage dependence of 
inactivation for the NaV1.9 current. On the contrary, the finding that activation of PKC can 
affect the voltage dependence of inactivation for NaV1.9 in the perforated patch recordings, 
where the augmentation does not occur, suggests that the effects of PMA are independent 
of the augmentation process. These results indicate that the spontaneous augmentation of 
NaV1.9 was regulated directly by PKA, and indirectly by PKC. 
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1. Introduction 
Voltage-gated sodium channels (Na
+ channels) mediate the transient increase in Na
+ conductance 
that underlies the action potential of neurons and other excitable cells. In mammals, a family of Na
+ 
channel α subunits (designated NaV1.1-NaV1.9) exhibit unique patterns of anatomical expression and 
varied functional and pharmacological properties [1,2]. 
Unmyelinated C-fibers originate from small primary afferent neurons of the dorsal root ganglion 
(DRG), and transmit nociceptive information to the central nervous system. Na
+ currents expressed in 
small DRG neurons can be classified into two categories on the basis of their relative sensitivity to 
tetrodotoxin (TTX); the first, TTX-sensitive (TTX-S) Na
+ currents and the second, TTX-resistant 
(TTX-R) Na
+ currents. TTX-R Na
+ currents can be further subdivided into the current mediated by 
NaV1.8, known as SNS [3–6], and the current mediated by NaV1.9, known as NaN [7–11]. 
The NaV1.9 current is characterized by a low activation threshold of about -60 mV and the 
depolarized steady-state inactivation (h∞) curve [7,11–13]. From these observations, the NaV1.9 
current may mainly regulate subthreshold excitability of small DRG neurons [7,10,11,13]. Our 
previous studies have demonstrated gradual and notable increase-decrease of the peak amplitude of the 
NaV1.9 current during whole-cell patch clamp recording (referred to as ‘spontaneous augmentation of 
NaV1.9’). The spontaneous augmentation of NaV1.9 was not observed in the presence intracellular 
ATP (3 mM) and by using nystatin-perforated patch clamp recording. These results suggest possible 
involvement of the intracellular environment in the spontaneous augmentation of NaV1.9 [11]. 
It is well known that protein kinases A and C (PKA and PKC), and phosphatases, as well as other 
proteins such as Ca
2+-calmodulin-dependent kinase, growth-factor-dependent receptor tyrosine 
kinases, extracellular signal-regulated kinases and heterotrimeric G proteins, also modulate Na
+ 
channels [14–16]. At present, endogenous factors that regulate the spontaneous augmentation of 
NaV1.9 have not been identified. In sensory neurons, activation of PKA and PKC affects the 
biophysical properties of Na
+ channels [1]. As a first step to the above issue, we focused on the 
possible involvement of the PKA and PKC pathways in the spontaneous augmentation of NaV1.9. For 
this purpose, in this study we examined the effects of activators and inhibitors of PKA and PKC on the 
spontaneous augmentation of NaV1.9, using NaV1.8 knock-out (KO) mice [5,11,13] to record the 
NaV1.9 current in isolation. 
2. Results and Discussion 
2.1. Characterization of the NaV1.9 current 
The detailed properties of the NaV1.9 current was already described in our previous reports 
[11,13,17]. A typical example of the NaV1.9 currents is shown in Figure 1. Currents were evoked by a 
200 ms test pulse (VT) from a holding potential (VH) of -80 mV. TTX-sensitive (TTX-S) Na
+ currents 
were completely eliminated by 200 nM TTX contained in the external solution. The NaV1.9 current 
had an activation threshold at about -60 mV (Figure 1a), which was more negative than thresholds for 
Na
+ currents mediated by NaV1.8 and other TTX-S Na
+ currents (about -40 mV) [13]. Time courses of 
activation and inactivation of the NaV1.9 current were extremely prolonged, particularly at lower Mar. Drugs 2010, 8                 
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activation voltages (Figure 1b). Figure 1c illustrates the current-voltage relationship for the currents 
shown in Figure 1b. 
Figure 1. Typical examples of the tetrodotoxin-resistant (TTX-R) Na
+ current mediated by 
NaV1.9. The NaV1.9 current was recorded from the small (diameter < 25 μm) dorsal root 
ganglion (DRG) neuron prepared from the NaV1.8 knock-out (KO) mouse. Currents were 
elicited by 200 ms test pulse (VT) from a holding potential (VH) of -80 mV. (a) The 
activation threshold for the NaV1.9 current. The NaV1.9 current could be activated at   
-60 mV, whereas VT to -70 mV failed to elicit. (b) A family of superimposed NaV1.9 
currents evoked by VTs between -70 and +10 mV in 10-mV increments from VH of   
-80 mV. The external solution contained 200 nM TTX. Voltage labels attached to traces 
indicate VTs. (c) The current-voltage curve for the NaV1.9 current shown in panel (b). Peak 
amplitudes of the currents were plotted against VT. 
 
2.2. Modification of the spontaneous augmentation of NaV1.9 by PKA and PKC 
As previously described [11,17], the peak amplitude of the NaV1.9 current remarkably increased 
during conventional whole-cell recording with control pipette solution. As shown in Figure 2, the peak 
amplitude of the NaV1.9 current gradually increased up to 18.7 ± 5.0-fold of the initial value (n = 10), 
and then diminished towards the initial value. The total duration of the spontaneous augmentation of Mar. Drugs 2010, 8                 
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NaV1.9 was 12.4 ± 1.7 min (n = 10). In addition, activation and inactivation kinetics of this current did 
not change during the spontaneous augmentation of NaV1.9 (Figure 2c). 
Figure 2. (a) Time courses of the NaV1.9 currents recorded with normal pipette solution. 
The NaV1.9 current was evoked by VT to -10 mV from VH of -80 mV, and command pulses 
were applied every 30 s. Then, selected traces were superimposed. (b) Typical example of 
the spontaneous augmentation of NaV1.9. Peak amplitudes of the NaV1.9 current were 
plotted as a function of time after onset of the spontaneous augmentation of NaV1.9. 
Numbers indicate the traces shown in panel (a). (c) Traces of the NaV1.9 currents shown in 
panel (a) were normalized and then superimposed. (d) Time courses of the NaV1.9 currents 
in all cases examined. 
 
 
Figure 3 summarizes the intensity changes of the spontaneous augmentation of NaV1.9, which were 
induced by compounds added to the pipette solution. In the presence of a PKA activator, forskolin  
(10  μM), the intensity of the spontaneous augmentation of NaV1.9 was significantly attenuated   
(2.1 ± 0.5-fold: n = 10). Although a PKA inhibitor, H-89 (10 μM). alone had no detectable effect on 
the intensity of the spontaneous augmentation of NaV1.9 (21.1 ± 7.3-fold: n = 10), the effect of 
forskolin was significantly inhibited by treatment with H-89 (17.3 ± 3.5-fold: n = 10). A PKC 
activator, PMA (100 nM), had significant suppressive effect on the intensity of the augmentation of 
NaV1.9 (2.0 ± 0.3-fold: n = 10). In the presence of a PKC inhibitor, calphostin C (100 nM), the effect 
of PMA on the augmentation of NaV1.9 was significantly inhibited (14.2 ± 2.8-fold: n = 10). Similarly 
to H-89, calphostin C alone had no discernable effect on the spontaneous augmentation of NaV1.9 
(11.3 ± 4.4-fold: n = 10). Mar. Drugs 2010, 8                 
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Figure 3. Modification of the spontaneous augmentation of NaV1.9 by addition of the PKA 
activator forskolin and the PKC activator PMA to the pipette solution. The ordinate shows 
the ratio of maximal amplitude during recording to the initial amplitude of the NaV1.9 
current (Imaximal/Iinitial). A ratio > 1 indicates the occurrence of the spontaneous 
augmentation of NaV1.9, whereas a ratio = 1 indicates no change or reduction of the peak 
amplitude of the NaV1.9 current. The plots are shown on a logarithmic scale. Circles 
indicate the ratios obtained for individual trials. Filled circles, control; open circles, treated 
groups. Horizontal bars indicate the mean values of each group. **P < 0.01 versus control,  
††P < 0.01 versus forskolin, and §P < 0.05 versus PMA. 
 
2.3. Possible involvement of PKA and PKC pathways in the voltage dependence of inactivation for the 
NaV1.9 current 
We next examined the effects of forskolin and PMA on the voltage dependence of inactivation for 
the NaV1.9 current (Figure 4). The voltage dependence of inactivation was determined by measuring 
peak amplitudes of the NaV1.9 currents evoked by VT to -10 mV from VHs of -70 mV (I1) and -120 mV 
(I2) intermittently (every 1 minute), and then the ratio of I1/I2 obtained from each group was compared. 
Just after commencing recording, there were no significant differences between each group (data not 
shown). 10 minutes after commencing recording, the presence of forskolin (10 μM) alone, or the  
co-presence of forskolin and H-89 (10 μM), did not significantly change the ratios of I1/I2 (1.00 ± 0.08: 
n = 8, and 0.99 ± 0.06: n = 6, respectively) versus control (0.99 ± 0.07: n = 8). On the contrary,  
100 nM PMA significantly reduced the ratio of I1/I2 (0.75 ± 0.07: n = 8) as compared to control. 
Calphostin C (100 nM) inhibited PMA-induced reduction of I1/I2 (0.91 ± 0.03: n = 5). Mar. Drugs 2010, 8                 
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Figure 4. The change of the voltage-dependence of inactivation for the NaV1.9 current by 
activation of PKC. The NaV1.9 currents were evoked by the pulse protocol shown in the 
diagram. We previously confirmed that the duration of VH for 3 s was sufficient to achieve 
steady state availability for NaV1.9 [11]. Peak amplitudes of the NaV1.9 currents (I1 and I2) 
were monitored for 10 min after commencing recording, and the resulting I1/I2 ratios were 
compared. *P < 0.05 versus control.  
 
2.4. The effect of PMA on the h∞ curve for the NaV1.9 current is reproducible under nystatin-
perforated patch clamp recording 
The spontaneous augmentation of NaV1.9 was prevented by using nystatin-perforated patch clamp 
recording [11]. Therefore, we further examined the effect of forskolin and PMA on the h∞ (voltage 
dependence of steady-state inactivation) curve for the NaV1.9 current in such a situation. The NaV1.9 
current was evoked by VT to 0 mV after various VPREs steps ranging from -120 mV to 10 mV in 10-mV 
steps for 3 s (see diagram of Figure 5). Figure 5 shows h∞ curves for the NaV1.9 current before 
(control) and after application of 100 nM PMA or 10 μM forskolin for 10 min. The h∞ curves were 
fitted to the Boltzmann equation: 
I/Imax = 1/{1+exp[(VPRE-V1/2)/k]} (1)
Where I is the peak amplitude of the NaV1.9 current obtained by VT, Imax is the peak amplitude of 
the NaV1.9 current evoked by VC, V1/2 is the half-maximum inactivation voltage, and k is the slope 
factor. We found significant differences (P < 0.05) between parameters obtained after PMA 
application (n = 5, V1/2 = -52.1 ± 5.4 mV, k = 5.17 ± 0.44 mV) versus control (n = 4,   
V1/2 = -44.7 ± 6.4 mV, k = 3.75 ± 0.15 mV). On the contrary, there was no significant change between 
values obtained after forskolin application (n = 5, V1/2 = -44.6 ± 2.1 mV,   
k = 4.44 ± 0.51 mV) from the control. Mar. Drugs 2010, 8                 
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Figure 5. The  h∞ curve for the NaV1.9 current under nystatin-perforated patch clamp 
recording. The diagram illustrates the pulse protocol. Two identical pulses to 0 mV for  
200 ms were applied 15 s prior (VC) and immediately subsequent (VT) to the conditioning 
pre-pulse (VPRE) of -120 to 10 mV for 3 s from VH of -80 mV. VC was delivered to 
minimize the error arising from possible fluctuation of the current (see experimental 
section). The pulse protocol was applied every 40 s. The peak amplitude of the current (IT) 
evoked by VT was divided by the peak amplitude of the current (IC) evoked by VC. The 
ratio of IT/IC was normalized and plotted against VPRE. The h∞ curve for NaV1.9 current was 
determined, before (control, filled circle) and 10 min after bath application of PMA (open 
circle) or forskolin (open square).  
 
2.5. Discussion 
The expression of the NaV1.9 current is confined to the subpopulation of primary afferent neurons 
with a small cell-body diameter similarly to the NaV1.8 current [4–8,10,11,18]. This observation 
suggests that NaV1.9 plays an important role in nociception, similar to NaV1.8. On the other hand, the 
electrophysiological properties of the NaV1.9 current differ notably from those of the NaV1.8 current, 
i.e., the NaV1.9 current has a more hyperpolarized activation threshold, much slower activation and 
inactivation kinetics, and a more depolarized h∞ curve [11,13]. These observations suggest that the role 
of NaV1.9 in nociception may be distinct from that of NaV1.8. 
It was reported that the sustained membrane depolarization (over several hundreds of milliseconds), 
which is resistant to TTX, is observed in myenteric ganglia [12]. In addition, we previously observed 
similar sustained membrane depolarization mediated by NaV1.9 in small DRG neurons [13]. The 
NaV1.9 current may have facilitatory functions in the generation of action potential. On the other hand, 
h∞ curves for other Na
+ currents are more depolarized than that of NaV1.9 [11,13]. Taking into 
consideration these properties, sustained activation of NaV1.9 may decrease the availability of other 
Na
+ channels, and then conversely act to inhibit generation of action potential. Thus, the regulation of 
membrane potential by NaV1.9 may be facilitatory or inhibitory to generating an action potential, in a 
context-dependent manner. Mar. Drugs 2010, 8                 
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In addition, we observed a sporadic and remarkable increase of the peak amplitude of the NaV1.9 
current followed by decrease of the peak amplitude during whole-cell patch clamp recording 
(“spontaneous augmentation of NaV1.9”) [11]. We previously reported that the spontaneous 
augmentation of NaV1.9 was inhibited by recording with the nystatin-perforated patch clamp 
technique, and in the presence of intracellular ATP [11,17]. These results suggest a possible 
involvement of the intracellular environment in the spontaneous augmentation of NaV1.9. 
Analyses of brain Na
+ channels have shown that the cytoplasmic loop between domains DI and DII 
of Na
+ channels possesses several shared PKA and PKC phosphorylation sites [19–20]. In addition, the 
inactivation gate has a unique site for PKC phosphorylation [22,23]. In fact, activation of PKA reduces 
the peak amplitude of brain Na
+ channels without the shift of the steady-state properties [20,24]. On 
the other hand, activation of PKC has regulatory effects on skeletal muscle Na
+ channels [25], brain 
Na
+ channels [26] and peripheral nerve Na
+ channel expressed in Xenopus oocytes [27]. However, the 
effects of PKA and PKC on the spontaneous augmentation of NaV1.9 in sensory neurons have not  
been investigated.  
First, we focused on the effect of PKA on the spontaneous augmentation of NaV1.9. The 
spontaneous augmentation of NaV1.9 was significantly suppressed in the presence of forskolin, and  
H-89 significantly inhibited this suppressive effect of forskolin (Figure 3). These results indicate that 
the spontaneous augmentation of NaV1.9 is suppressed by activation of PKA. It is well known that the 
amplitude of Na
+ current is strongly affected by steady-state inactivation of the channel. However, 
forskolin did not change the h∞ curve parameters for the NaV1.9 current in comparison with the control 
(Figures 4 and 5). This suggests that inhibition of the spontaneous augmentation of NaV1.9 by PKA 
activation was not due to the hyperpolarizing shift of the h∞ curve for the NaV1.9 current. 
Next, we focused on the effect of PKC on the spontaneous augmentation of NaV1.9. PMA 
significantly reduced the intensity of augmentation, and the effect of PMA was significantly 
suppressed by Calphostin C (Figure 3). However, application of PMA induced the hyperpolarizing 
shift of the voltage dependence of inactivation for the NaV1.9 current. Thus, apparent suppression of 
the spontaneous augmentation of NaV1.9 by PMA was largely due to hyperpolarizing shift of the h∞ 
curve for the NaV1.9 current.  
A similar phenomenon has also been reported by Baker et al., who showed that intracellular GTP 
[28] or activation of PKC [29] induces the up-regulation of the NaV1.9 current. There are distinct 
dissimilarities between the up-regulation reported by Baker et al. and the spontaneous augmentation of 
NaV1.9 described in the present study and also in our previous reports [11,13,17]. Namely, (1) the  
up-regulation reported by Baker et al. was observed in the presence of intracellular ATP. On the 
contrary, the spontaneous augmentation of NaV1.9 in our experiments occurred only in the absence of 
intracellular ATP. (2) the up-regulation reported by Baker et al. was mediated by intracellular GTP or 
activation of PKC. On the other hand, we find that intracellular GTP has no effect on the spontaneous 
augmentation of NaV1.9 (unpublished data). (3) Baker et al. showed only an increment of peak 
amplitude of the NaV1.9 current, and did not show the entire time course of the phenomenon [28,29]. 
The spontaneous augmentation of NaV1.9 was composed of an increase and a subsequent decrease of 
peak amplitude of the NaV1.9 current. From these observations, the up-regulation reported by Baker  
et al. may be distinct from the spontaneous augmentation of NaV1.9 in our studies. Mar. Drugs 2010, 8                 
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A recent behavioral study showed that the PKA inhibitor, H-89, suppresses bee venom-induced 
mechanical hyperalgesia in rats [30], and the activation of PKA is conductive to the inflammatory 
mechanical hyperalgesia [31,32]. In addition, activity of specific PKC isozymes is increased in 
inflammatory-pain models in rats [33–36]. From these observations, the NaV1.9 channel may be 
regulated not to increase the amplitude of the NaV1.9 current, i.e., the spontaneous augmentation of 
NaV1.9 under pathological condition by PKA and/or PKC activation. 
Recently, it has been reported that NaV1.9 underlies nociceptive behavior after peripheral 
inflammation in NaV1.9 KO mice [37]. In addition, histochemical study on NaV1.9 channel proteins in 
axons of normal and complete Freund’s adjuvant-inflamed rats showed significant decrease of the 
proportion of NaV1.9-labeled unmyelinated axons, and no change in the proportion of labeled 
myelinated axons following inflammation [18]. Taken together, the NaV1.9 current contributes to pain 
signaling, and may alter under pathophysiological conditions. 
3. Experimental Section 
3.1. Isolation of single DRG neurons and cell culture 
The protocols were approved by Hiroshima University Animal Ethics Committee. Dissociation of 
single DRG neurons and their culture was described previously. [11,13]. Briefly, adult mice were 
sacrificed by cervical dislocation under ethylcarbamate anesthesia (3 mg/g; Wako Pure Chemicals, 
Osaka, Japan). DRGs from all segments of the spinal cord were dissected from Nav1.8 KO mice [5] 
and desheathed in ice-cold Ca
2+/Mg
2+-free phosphate-buffered saline (PBS(-)). The isolated DRGs 
were incubated sequentially in PBS(-) containing 0.2% collagenase (Wako Pure Chemicals) and 0.1% 
trypsin (Sigma, St. Louis, Mo., USA), each for 20 min at 37 °C. DRGs were then dissociated by 
trituration with fire-polished Pasteur pipettes in culture medium composed of Dulbecco’s modified 
Eagle medium 10% (vol./vol.) heat-inactivated fetal calf serum. 
The dissociated cells were plated on 35 mm plastic tissue-culture dishes pre-coated with 0.01% 
poly-L-lysine (Sigma) and maintained in culture medium supplemented with penicillin (100 IU/mL) 
and streptomycin (100 µg/mL). All cultured cells were maintained at 37 °C in 5% CO2/95% air. Cells 
were used for experiments after short-term culture (4–12 h after plating). At this time in culture, 
neurite outgrowth was not observed. We defined DRG neurons that were smaller than 25 μm in 
diameter as small neurons [13,28], and small neurons thus defined were used throughout the study. 
3.2. Electrophysiology 
Voltage clamp recordings were performed using an Axopatch 200A amplifier (Axon Instruments, 
Union City, CA, USA). The Na
+ currents were recorded by using either the conventional whole-cell 
patch clamp technique [38] or the nystatin-perforated patch clamp technique [39] at room temperature 
(22–24 °C). Data were low-pass-filtered at 5 kHz with a four-pole Bessel filter and sampled digitally at 
25–100 kHz. In some experiments, capacitive and leakage currents were subtracted digitally using the 
P-P/4 procedure [4]. 
The pipette (internal) solution contained 10 mM NaCl, 110 mM CsCl, 20 mM tetra-ethylammonium 
(TEA)-Cl, 2.5 mM MgCl2, 5 mM 4-2-hydroxylethyl-1-piperazine-ethanesulfonic acid (HEPES) and  Mar. Drugs 2010, 8                 
 
 
737
5 mM ethylene glycol tetraacetic acid (EGTA). The pH of the pipette solution was adjusted to 7.0 with 
CsOH. Osmolarity was adjusted to 290 mosmol/kg with glucose. A part of the experiments were 
performed with the pipette solution containing phorbol 12-myristate 13-acetate (PMA), calphostin C, 
forskolin and H-89 (Sigma). For the pipette solution used in nystatin-perforated patch recordings, a 
stock solution containing 10mg/mL nystatin (Wako) was prepared and added to the pipette solution to 
final concentration of 500 µg/mL. Patch clamp pipettes were made from borosilicate capillary by using 
a PP-83 puller (Narishige, Tokyo, Japan) and heat-polished with MF-83 microforge (Narishige). The 
DC resistance of patch electrodes was 1–1.5 MΩ for the conventional whole-cell patch and 3–5 MΩ 
for the nystatin-perforated patch, respectively. 
The external solution contained 100 mM NaCl, 30 mM TEA-Cl, 5 mM CsCl, 1.8 mM CaCl2, 1 mM 
MgCl2, 0.1 mM CdCl2, 5 mM HEPES, 25 mM glucose, 5 mM 4-aminopyrimidine (4-AP). The pH of 
the external solution was adjusted to 7.4 with HCl. TEA-Cl and 4-AP were added to abolish K
+ 
currents and CdCl2 was added to abolish Ca
2+ currents [4]. In addition, TTX (Sanko, Tokyo, Japan) 
was added to eliminate TTX-S Na
+ currents. Osmolarity was adjusted to 290 mosmol/kg with glucose. 
A part of the experiments were performed with the external solution containing PMA and forskolin 
(Sigma). Liquid junction potentials between pipette and external solutions were compensated by 
adjusting the zero current potential to the liquid junction potential. Only cells showing an adequate 
voltage and space clamp [11] were used. 
When measuring ion channel kinetics, it generally take a considerable time to execute the protocol, 
since a sufficient recovery period for the channel must be allowed between each test pulse (VT). For 
various reasons, the amplitudes of Na
+ currents are not always constant during recording, e.g., due to 
run-down of the current or to instability of the seal condition. This can be checked by applying a 
control pulse (VC) before each VT. To avoid a possible time-dependent fluctuation of the analysis, VC to 
a fixed voltage as applied 15 s before VT or conditioning pre-pulse (VPRE). The amplitude of the current 
(IC) evoked by VC served as a calibrator. The results are given as mean ± standard error of the mean 
(S.E.M.). Statistical significance of differences was determined using Wilcoxon t-test and Mann-
Whitney U-test. Differences were considered significant if P < 0.05.  
4. Conclusions 
The spontaneous augmentation of the NaV1.9 current was significantly suppressed by activation of 
PKA, whereas activation of PKA did not affect the voltage dependence of inactivation for the NaV1.9 
current. On the contrary, the finding that activation of PKC can affect the voltage dependence of 
inactivation for NaV1.9 in the perforated patch recordings, where the augmentation does not occur, 
suggests that the effects of PMA are independent of the augmentation process. These results indicate 
that the spontaneous augmentation of NaV1.9 was regulated directly by PKA, and indirectly by PKC. 
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